These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 28665686)

  • 1. Cardiovascular Disease Does Not Predict Exacerbation Rate or Mortality in Chronic Obstructive Pulmonary Disease.
    Jones PW; Mullerova H; Agusti A; Decramer M; Adamek L; Raillard A; Zhu CQ; Wedzicha JA
    Am J Respir Crit Care Med; 2018 Feb; 197(3):400-403. PubMed ID: 28665686
    [No Abstract]   [Full Text] [Related]  

  • 2. Defining the relationship between COPD and CVD: what are the implications for clinical practice?
    Morgan AD; Zakeri R; Quint JK
    Ther Adv Respir Dis; 2018; 12():1753465817750524. PubMed ID: 29355081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic Obstructive Pulmonary Disease in Hispanics. A 9-Year Update.
    Díaz AA; Celli B; Celedón JC
    Am J Respir Crit Care Med; 2018 Jan; 197(1):15-21. PubMed ID: 28862879
    [No Abstract]   [Full Text] [Related]  

  • 4. The Swedish CArdioPulmonary BioImage Study: objectives and design.
    Bergström G; Berglund G; Blomberg A; Brandberg J; Engström G; Engvall J; Eriksson M; de Faire U; Flinck A; Hansson MG; Hedblad B; Hjelmgren O; Janson C; Jernberg T; Johnsson Å; Johansson L; Lind L; Löfdahl CG; Melander O; Östgren CJ; Persson A; Persson M; Sandström A; Schmidt C; Söderberg S; Sundström J; Toren K; Waldenström A; Wedel H; Vikgren J; Fagerberg B; Rosengren A
    J Intern Med; 2015 Dec; 278(6):645-59. PubMed ID: 26096600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Disease and Chronic Obstructive Pulmonary Disease: Adding a Third Dimension to the ABE Global Initiative for Chronic Obstructive Lung Disease 2023 Chronic Obstructive Pulmonary Disease Classification.
    Kostikas K; Gogali A; Hillas G
    Am J Respir Crit Care Med; 2023 Aug; 208(4):502-504. PubMed ID: 37311251
    [No Abstract]   [Full Text] [Related]  

  • 6. Implication of the Global Initiative for Chronic Obstructive Lung Disease 2023 report for resource-limited settings: tracing the G in the GOLD.
    Kirenga BJ; Alupo P; van Gemert F; Jones R
    Eur Respir J; 2023 Jun; 61(6):. PubMed ID: 37321612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Rotterdam Study: 2010 objectives and design update.
    Hofman A; Breteler MM; van Duijn CM; Janssen HL; Krestin GP; Kuipers EJ; Stricker BH; Tiemeier H; Uitterlinden AG; Vingerling JR; Witteman JC
    Eur J Epidemiol; 2009; 24(9):553-72. PubMed ID: 19728115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comment on "Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease".
    Golpe R; Figueira-Gonçalves JM
    Arch Bronconeumol; 2024 Jun; 60(6):391. PubMed ID: 38521645
    [No Abstract]   [Full Text] [Related]  

  • 9. Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease: Response to Additional Considerations.
    de Miguel-Díez J; Gómez Doblas JJ
    Arch Bronconeumol; 2024 Jun; 60(6):392-393. PubMed ID: 38714383
    [No Abstract]   [Full Text] [Related]  

  • 10. Rome Criteria for Exacerbation of Chronic Obstructive Pulmonary Disease: Not Built in a Day.
    Bhatt SP
    Am J Respir Crit Care Med; 2022 May; 205(9):1124-1125. PubMed ID: 35196475
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk of Cardiovascular and Cerebrovascular Events in COPD Patients Treated With Long-Acting β
    Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA
    Ann Pharmacother; 2017 Nov; 51(11):945-953. PubMed ID: 28677404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluticasone Furoate, Vilanterol, and Lung Function Decline in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk.
    Calverley PMA; Anderson JA; Brook RD; Crim C; Gallot N; Kilbride S; Martinez FJ; Yates J; Newby DE; Vestbo J; Wise R; Celli BR;
    Am J Respir Crit Care Med; 2018 Jan; 197(1):47-55. PubMed ID: 28737971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excess Ventilation in Chronic Obstructive Pulmonary Disease-Heart Failure Overlap. Implications for Dyspnea and Exercise Intolerance.
    Rocha A; Arbex FF; Sperandio PA; Souza A; Biazzim L; Mancuso F; Berton DC; Hochhegger B; Alencar MCN; Nery LE; O'Donnell DE; Neder JA
    Am J Respir Crit Care Med; 2017 Nov; 196(10):1264-1274. PubMed ID: 28665692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of Patients With Congestive Heart Failure or Chronic Obstructive Pulmonary Disease Readmissions Within 30 Days Following an Acute Exacerbation.
    Castillo A; Edriss H; Selvan K; Nugent K
    Qual Manag Health Care; 2017; 26(3):152-159. PubMed ID: 28665906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
    Han MK; Quibrera PM; Carretta EE; Barr RG; Bleecker ER; Bowler RP; Cooper CB; Comellas A; Couper DJ; Curtis JL; Criner G; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Krishnan JA; Martinez CH; Pirozzi CB; O'Neal WK; Rennard S; Tashkin DP; Wedzicha JA; Woodruff P; Paine R; Martinez FJ;
    Lancet Respir Med; 2017 Aug; 5(8):619-626. PubMed ID: 28668356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood eosinophil count and exacerbation risk in patients with COPD.
    Kerkhof M; Sonnappa S; Postma DS; Brusselle G; Agustí A; Anzueto A; Jones R; Papi A; Pavord I; Pizzichini E; Popov T; Roche N; Ryan D; Thomas M; Vogelmeier C; Chisholm A; Freeman D; Bafadhel M; Hillyer EV; Price DB
    Eur Respir J; 2017 Jul; 50(1):. PubMed ID: 28729477
    [No Abstract]   [Full Text] [Related]  

  • 17. The Association of Depressive Symptoms With Rates of Acute Exacerbations in Patients With COPD: Results From a 3-year Longitudinal Follow-up of the ECLIPSE Cohort.
    Yohannes AM; Mülerová H; Lavoie K; Vestbo J; Rennard SI; Wouters E; Hanania NA
    J Am Med Dir Assoc; 2017 Nov; 18(11):955-959.e6. PubMed ID: 28733182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential role of endothelial dysfunction and platelet activation in the development of thrombotic risk in COPD patients.
    Malerba M; Nardin M; Radaeli A; Montuschi P; Carpagnano GE; Clini E
    Expert Rev Hematol; 2017 Sep; 10(9):821-832. PubMed ID: 28693343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Airway obstruction and the risk of myocardial infarction and death from coronary heart disease: a national health examination survey with a 33-year follow-up period.
    Mattila T; Vasankari T; Rissanen H; Knekt P; Puukka P; Heliövaara M
    Eur J Epidemiol; 2018 Jan; 33(1):89-98. PubMed ID: 28688065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbid Heart Disease in Patients with COPD is Associated with Increased Hospitalization and Mortality - A 15-Year Follow-Up.
    Giezeman M; Sundh J; Athlin Å; Lisspers K; Ställberg B; Janson C; Montgomery S; Kisiel MA; Nager A; Sandelowsky H; Hasselgren M
    Int J Chron Obstruct Pulmon Dis; 2023; 18():11-21. PubMed ID: 36644219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.